Objectives of Training To provide you with an overview of MSD Informatics Software. To provide you with sufficient training to be able to use MSD Informatics.

Slides:



Advertisements
Similar presentations
2/9/2014 The Prevalence and Prognostic Significance of ECG Abnormalities For: ECG in Ischemic Heart Disease By: V. Froelicher, MD Palo Alto VAHCS and Stanford.
Advertisements

Cardiovascular Risk Assessment
Diabetes Overview Managing Diabetes in Primary Care.
Summary Prepared by Melvyn Rubenfire, MD
Task Force on Diabetes and CVD (ESC and EASD) European Heart Journal 2007;28:
CVD risk estimation and prevention: An overview of SIGN 97.
The INSIGHT study - Reliable blood pressure control and additional benefits for hypertensive patients Anthony M Heagerty Department of Medicine Manchester.
Etiology Primary hypertension 95% of all cases Secondary hypertension – 5% of all cases – Chronic renal disease – most common White coat hypertension –
CVD prevention & management: a new approach for primary care Rod Jackson School of Population Health University of Auckland New Zealand.
Absolute cardiovascular disease risk Assessment and Early Intervention Dr Michael Tam Lecturer in Primary Care
JBS2 Some highlights from the JBS2 guidelines on prevention of cardiovascular disease in clinical practice Jim McMorran GP trainer Visiting Senior Clinical.
Cohort Studies.
Chapter 2: Identification and Care of Patients With CKD 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
Chapter 4 Cardiovascular disease
Heart Disease Map.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Cardiovascular Epidemiology: Definitions Historical Perspectives and Assessing Risk of CVD Recent trends and population differences in CHD and CHD risk.
Ischemic Heart Diseases IHD
Cardiovascular Disease in Women Module III: Risk Assessment Tool.
LIFESTYLE MODIFICATIONS FOR PREVENTING HEART DISEASE [e.g. HEART ATTACKS] [ primary prevention of coronary artery disease ] DR S. SAHAI MD [Med.], DM [Card]
Healthy People 2010 Focus Area 12: Heart Disease and Stroke
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
Identifying the Presence of Peripheral Artery Disease in Patients With and Without Diabetes Lori Brown, PharmD and Charles Herring, PharmD, BCPS, CPP University.
December Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation?
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
CVD preventive interventions WORKSHOP Jurate Klumbiene Kaunas University of Medicine, Kaunas, Lithuania.
Hypertension. Definition: blood pressure Blood pressure is the force of blood pushing through the arteries and is necessary for maintaining our circulation.
Systemic Hypertension. Systemic blood pressure measures 140/90 mm Hg or higher on at least two occasions a minimum of 1 to 2 weeks apart.
Coronary Artery Disease Angina Pectoris Unstable Angina Variant Angina Joseph D. Lynch, MD.
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
EXAM 1.A normal adult should have their BP checked at least how often? 2.What level of CVD risk over 10 years is considered high risk for primary prevention?
10 Points to Remember on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsTreatment of Blood Cholesterol to Reduce.
Modelling the development of, and treatments for, heart disease and stroke. Tushar Chatterjee, Angus Macdonald & Howard Waters Heriot-Watt University,
Tina Huang.  Aimed at people aged 40 – 74  Risk assessment and management programme to prevent or delay the onset of diabetes, heart and kidney disease.
NICE GUIDELINES HYPERTENSION Masroor Syed. Latest Issue June 2006 Evidence Based uickrefguide.pdf
ASSIGN Paul Ryan, Clinical Director, North Glasgow CHCP.
10 Points to Remember on the Assessment of Cardiovascular RiskAssessment of Cardiovascular Risk Summary Prepared by Melvyn Rubenfire, MD.
Predicting risk of cardiovascular disease and the cost-effectiveness of interventions in Thailand Stephen Lim On Behalf of the Setting Priorities using.
Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension The First Outcomes Trial of Initial Therapy With.
Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.
International Guidelines for Prevention of Atherosclerotic Cardiovascular Disease Prof. Mohamed Sobhy, MD, FACC Professor of Cardiology, Alex. University.
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
Risk Factors for Coronary Heart Disease.. Did you know that…. In the UK, someone has a heart attack every 2 minutes, that’s 260,000 people per year. In.
Section III. Assessment of Overall Cardiovascular Risk in Hypertensive Patients 2015 Canadian Hypertension Education Program Recommendations.
Chapter 2: Identification and Care of Patients With CKD 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Baseline characteristics. Patient flow Completed Completed Perindopril Placebo Randomised Not randomised Registered.
ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)
Case 2: Dyslipidaemia in Type 2 Diabetes Mellitus.
The MICRO-HOPE. Microalbuminuria, Cardiovascular and Renal Outcomes in the Heart Outcomes Prevention Evaluation Reference Heart Outcomes Prevention Evaluation.
Quality and Outcomes Framework The national Quality and Outcomes Framework (QOF) was introduced as part of the new General Medical Services (GMS) contract.
ResultsIntroduction Atrial Fibrillation (AF) affects 1.2% 1 of the population and 10% of those over the age of 75 2 It is the commonest arrhythmia in primary.
Left Ventricular Filling Pressure by Doppler Echocardiography in Patients With End-Stage Renal Disease Angela Y-M Wang, Mei Wang, Christopher W-K Lam,
Case 1: Elevated LDL-C in a Young Adult. Page 2 of 10 *DALY; disability-adjusted life years Routine checkup:  Age:33 years  Sex: male  Status: Except.
Search strategy and results Amir Kashani, et al. Circulation. 2006;114:
From: Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort Study Ann Intern Med. 2015;163(5):
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
Background/Objective
Figure 1: Questions included in questionnaire
Hypertension Hanna K. Al-Makhamreh, MD FACC Interventional Cardiology.
The Anglo Scandinavian Cardiac Outcomes Trial
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations Cardiology 2015;132: DOI: / Fig. 1. Semilogarithmic.
Prevention Cardiovascular disease
by Peter Ueda, Thomas Wai-Chun Lung, Philip Clarke, and Goodarz Danaei
by Peter Ueda, Thomas Wai-Chun Lung, Philip Clarke, and Goodarz Danaei
Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension The First Outcomes Trial of Initial Therapy With.
What is cardiovascular disease?
ASCORE : An up-to-date cardiovascular risk score for hypertensive patients reflecting. contemporary clinical practices developed. using the ASCOT trial.
Goals & Guidelines A summary of international guidelines for CHD
Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.
Presentation transcript:

Objectives of Training To provide you with an overview of MSD Informatics Software. To provide you with sufficient training to be able to use MSD Informatics Software in your practice To answer any questions that you have regarding MSD Informatics and our products

Clinical Risk Collaboration with Sandwell PCT & University of Birmingham Produces stratified list of all patients with real or probable >20% CVD risk over ten years CVD Screening Ranking Tool: Filters patient population - –Non CVD / Non Diabetic / Non Hypertensive –Framingham CVD calculator with additional risk for FH and ethnicity; unknown data substituted using ‘look up’ tables (Health Survey for England 2003)

Clinical Risk - Definitions CVD Risk Definition used in Clinical Risk –The Framingham CVD Risk Calculator predicts risk from any cardiovascular disease and uses the CHD Framingham score based on death from CHD (sudden or non-sudden), myocardial infarction, angina pectoris and coronary insufficiency and additionally includes stroke, transient ischemia, heart failure and peripheral vascular disease. –This algorithm tends to be higher than those used by JBS2 especially if they are not factoring in Family History and Ethnicity.

Clinical Risk - Definitions Excluded Patient Groups –The following patients should not have their risk calculated as they are already considered to be at high enough risk to justify lifestyle and other interventions (antithrombotic, antihypertensive and lipid lowering therapies). Patients with atherosclerotic cardiovascular disease Hypertension (≥160/100 mmHg) with target organ damage Patients with type 1 or 2 diabetes mellitus Renal dysfunction (including diabetic nephropathy) Familial hypercholesterolaemia, familial combined hyperlipidaemia or other inherited dyslipidaemia Patients on Lipid Lowering Therapy

Clinical Risk - Definitions The South Asian Male Weighting Definition –Ethnic groups within Britain have differing risk of coronary heart disease (CHD) and cardiovascular disease (CVD) at the same level of risk factors. This calculator uses the Risk Factor accepted by draft NICE Lipid Guidelines 2007 and adjusts for ethnic groups and is based on a re-calibration of the Framingham risk equations. –The Risk is increased by a factor of 1.4 for South Asian men

Clinical Risk - Definitions Family History of Premature CHD –A family history of CHD means CHD in a first degree female relative aged under 65 or CHD in a first degree male relative aged under 55. This means younger than 55 years in fathers, sons or brothers or younger than 65 years in mothers, daughters or sisters. –Risk is increased by a factor of 1.5 for individuals with a family history of premature CHD. This follows recommendations in the draft NICE lipid guidelines of –If a patient has BOTH a Family History and is South Asian then assume a risk factor of 1.5

Clinical Risk - Definitions LVH –Left ventricular hypertrophy (LVH) is ascertained from a resting ECG and the calculator will look for the presence of the relevant Read codes. Smoking Status –Smoking status reflects the exposure to tobacco within the last 12 months. The calculator will look for the presence of the relevant Read codes.

Training Materials Clinical Risk – How Do I? 1 View Relevant Clinical Notes? 2 Filter Patients? 3 Display Patient Lists? 4 Display Patient Demographics? 5 Display Patient Changes? 6 Display Risk Cohorts? 7 Set-up Mail Merge? 8 Export Data?

Training Materials Clinical Audit – How Do I? 1 View Relevant Clinical Notes? 2 Setup Search Filters? 3 Search on Specific Words? 4 Display Patient Demographics? 5 Display Patient Changes? 6 Display Historical Trends? 7 Set-up Mail Merge? 8 Export Data?

Training Materials Contract Manager – How Do I? 1 Change from Points to Rolling Points? 2 Prioritise Patients? 3 Display Patient Lists? 4 View Historical Trends? 5 View Indicators in a Disease Area?